IL1B and irritable bowel syndrome: DSS treatment is generally used to mimic intestinal bowel disease (IBD) characterized by an acute but intense gut inflammation, a reduction of colon length, DAI values above 10 and significant increased plasma levels of pro-inflammatory cytokines (TNFα, IL1β, IFNγ) (27).